 Antihypertensive Agents
"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
| Descriptor ID |
D000959
|
| MeSH Number(s) |
D27.505.954.411.162
|
| Concept/Terms |
Antihypertensive Agents- Antihypertensive Agents
- Agents, Antihypertensive
- Antihypertensives
- Anti-Hypertensives
- Anti Hypertensives
- Antihypertensive Drugs
- Drugs, Antihypertensive
- Anti-Hypertensive Agents
- Agents, Anti-Hypertensive
- Anti Hypertensive Agents
- Anti-Hypertensive Drugs
- Anti Hypertensive Drugs
- Drugs, Anti-Hypertensive
|
Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".
This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 | | 1996 | 1 | 1 | 2 | | 1997 | 2 | 0 | 2 | | 1998 | 0 | 1 | 1 | | 1999 | 2 | 0 | 2 | | 2000 | 3 | 3 | 6 | | 2001 | 1 | 1 | 2 | | 2002 | 4 | 2 | 6 | | 2003 | 5 | 1 | 6 | | 2004 | 6 | 1 | 7 | | 2005 | 8 | 4 | 12 | | 2006 | 9 | 3 | 12 | | 2007 | 5 | 3 | 8 | | 2008 | 6 | 6 | 12 | | 2009 | 9 | 7 | 16 | | 2010 | 11 | 12 | 23 | | 2011 | 13 | 7 | 20 | | 2012 | 13 | 6 | 19 | | 2013 | 9 | 6 | 15 | | 2014 | 14 | 5 | 19 | | 2015 | 14 | 4 | 18 | | 2016 | 10 | 11 | 21 | | 2017 | 7 | 10 | 17 | | 2018 | 10 | 8 | 18 | | 2019 | 8 | 5 | 13 | | 2020 | 9 | 3 | 12 | | 2021 | 8 | 3 | 11 | | 2022 | 2 | 8 | 10 | | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.
-
Lowe RN, Kovac N, Lobo I, Billups SJ. Centrally supported clinical pharmacist intervention to reduce clinical inertia in hypertension. Am J Health Syst Pharm. 2023 03 21; 80(7):457-461.
-
Smith SM, Winterstein AG, Gurka MJ, Walsh MG, Keshwani S, Libby AM, Hogan WR, Pepine CJ, Cooper-DeHoff RM. Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network. J Am Heart Assoc. 2023 01 03; 12(1):e026652.
-
Gumz ML, Shimbo D, Abdalla M, Balijepalli RC, Benedict C, Chen Y, Earnest DJ, Gamble KL, Garrison SR, Gong MC, Hogenesch JB, Hong Y, Ivy JR, Joe B, Laposky AD, Liang M, MacLaughlin EJ, Martino TA, Pollock DM, Redline S, Rogers A, Dan Rudic R, Schernhammer ES, Stergiou GS, St-Onge MP, Wang X, Wright J, Oh YS. Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension - 2021 NHLBI Workshop Report. Hypertension. 2023 03; 80(3):503-522.
-
Craighead DH, Tavoian D, Freeberg KA, Mazzone JL, Vranish JR, DeLucia CM, Seals DR, Bailey EF. A multi-trial, retrospective analysis of the antihypertensive effects of high-resistance, low-volume inspiratory muscle strength training. J Appl Physiol (1985). 2022 10 01; 133(4):1001-1010.
-
Rifas-Shiman SL, Aris IM, Bailey C, Daley MF, Heerman WJ, Janicke DM, Lin PD, Petimar J, Block JP. Changes in obesity and BMI among children and adolescents with selected chronic conditions during the COVID-19 pandemic. Obesity (Silver Spring). 2022 10; 30(10):1932-1937.
-
Hussain A, Virani SS, Zheng L, Gluckman TJ, Borden WB, Masoudi FA, Maddox TM. Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry. J Am Heart Assoc. 2022 06 07; 11(11):e024107.
-
Furgeson SB, Linas S. Chlorthalidone and Advanced Chronic Kidney Disease. Clin J Am Soc Nephrol. 2022 07; 17(7):1076-1078.
-
Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson K, Haas DM, Plante L, Metz T, Casey B, Esplin S, Longo S, Hoffman M, Saade GR, Hoppe KK, Foroutan J, Tuuli M, Owens MY, Simhan HN, Frey H, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Kinzler W, Su E, Krishna I, Nguyen N, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Galis ZS, Harper L, Ambalavanan N, Geller NL, Oparil S, Cutter GR, Andrews WW. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022 05 12; 386(19):1781-1792.
-
Kurtz JD, Rubio AE, Johnston TA, Morray BH, Jones TK. Late Outcomes of Transcatheter Coarctation Intervention in Infants with Biventricular Anatomy. Pediatr Cardiol. 2022 Oct; 43(7):1438-1443.
-
Douwes JM, Zijlstra WMH, Rosenzweig EB, Ploegstra MJ, Krishnan US, Haarman MG, Roofthooft MTR, Postmus D, Hillege HL, Ivy DD, Berger RMF. Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine. Ann Am Thorac Soc. 2022 02; 19(2):227-237.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|